Vinorelbine and prednisone in older cancer patients with hormone-refractory metastatic prostate cancer. A phase II study.

Tumori

Volumn 89, Issue 1, 2003, Pages 26-30

  Tralongo, Paolo ^a   Bollina, Roberto ^a   Aiello, Rosanna ^a   Di Mari, Anna ^a   Moruzzi, Giovanni ^a   Beretta, Gianni ^a   Mauceri, Gaetano ^a   Conti, Gianfranco ^a  

^a G Di Maria Hospital   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIANDROGEN; ANTINEOPLASTIC AGENT; ANTINEOPLASTIC HORMONE AGONISTS AND ANTAGONISTS; DRUG DERIVATIVE; NAVELBINE; PREDNISONE; PROSTATE SPECIFIC ANTIGEN; VINBLASTINE;

AGED; ARTICLE; CLINICAL TRIAL; DRUG ADMINISTRATION; DRUG RESISTANCE; HUMAN; IMMUNOLOGY; MALE; METABOLISM; ORAL DRUG ADMINISTRATION; PATHOLOGY; PHASE 2 CLINICAL TRIAL; PROSTATE TUMOR; TREATMENT OUTCOME;

ADMINISTRATION, ORAL; AGED; ANDROGEN ANTAGONISTS; ANTINEOPLASTIC AGENTS, HORMONAL; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; DRUG ADMINISTRATION SCHEDULE; DRUG RESISTANCE, NEOPLASM; HUMANS; MALE; PREDNISONE; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; TREATMENT OUTCOME; VINBLASTINE;

MLCS; MLOWN;

EID: 0038024245     PISSN: 03008916     EISSN: None     Source Type: Journal    
DOI: 10.1177/030089160308900106     Document Type: Article

References (0)